We Can Now Customize Cancer Cures, Tumor by Tumor

But can any company afford to manufacture one-off medical treatments?

A blood vessel formation providing cancer cells (whose nuclei are shown in blue) with oxygens and nutrients. Illustration: Alfred Pasieka/Science Library/Getty Images

By Adam Piore

The first time someone pitched Genentech’s senior leadership on a personalized cancer vaccine, it did not go well. “I thought there was going to be a riot,” Ira Mellman, then Genentech’s head of research oncology, recalls.

--

--

--

MIT Technology Review

Recommended from Medium

Can Men Get Ovarian Cancer?

The Poacher and the Lioness: My Reckoning with Miscarriage and Medical Mismanagement

Russian creators of pulmonary plague, twin sister of COVID-19, off to save Italy

Saffron has anti-cancer plants

Saffron has anti-cancer plants,saffron seller,wholesale saffron,wholesale iranian saffron,saffron price,saffron exporter,saffron export,saffron iran,Saffron has anti-cancer plants

Guide for Coronavirus 19 Phase One “Ease of Restrictions” for North Carolina Small Businesses

From the photographer: Photographing tropical diseases

What No One Tells Black Women About Fibroids

5 Ways a CRO with CDMO Services Can Help with Phase 1 Clinical Trials

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
MIT Technology Review

MIT Technology Review

Reporting on important technologies and innovators since 1899

More from Medium

The Spartan collaboration with York Dispatch gives student writers’ talents a much bi audience

Henosis Foundation Awards Kenneth W.

Tourism in San Francisco

Nuclear Energy Could Have the Same Revolution Wind and Solar Had